Biologic Formulation (Uplizd)

Uplizd's secure multi-agent AI platform moves high-concentration (>=250mg/mL) biologics from sequence to a defensible formulation strategy, compressing early CMC from a minimum 10mo to 2mo and saving $5M loss per program. It triages sequence-level liabilities, models viscosity and self-association risk, designs excipient systems, and interprets stability. Open-weight models run inside your network perimeter, so proprietary sequences never leave.